50090-2870 NDC - DILTIAZEM HYDROCHLORIDE ()

Drug Information

No.	Package Code	Package Description	Billing Unit
1	50090-2870-0	30 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE (50090-2870-0)	EA
2	50090-2870-1	90 CAPSULE, COATED, EXTENDED RELEASE in 1 BOTTLE (50090-2870-1)	EA

Field Name	Field Value	Definition
PRODUCT NDC	50090-2870	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	Diltiazem Hydrochloride	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAME SUFFIX	Extended-Release	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE	10/1/2015	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
MARKETING CATEGORY NAME	ANDA	The translation of the dosage form Code submitted by the firm.
APPLICATION NUMBER	ANDA074984	This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAME	A-S Medication Solutions	This is the date that the labeler indicates was the start of its marketing of the drug product.